Jun Meng
Impact in
-
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Guifang Li (1 shared paper)Yanyan Yu (1 shared paper)Lu Liu (1 shared paper)Cong Tan (1 shared paper)Yongping Liu (1 shared paper)Weiqi Sheng (1 shared paper)Yunpu Wang (1 shared paper)Weiwei Weng (1 shared paper)
- Journals
- Experimental Cell Research (2 papers)Genes & Diseases (1 paper)Life Sciences (1 paper)Frontiers in Medicine (1 paper)Stress and Health (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jun Meng
21 papers receiving 413 citations
Peers
Comparison fields: 5 of 65
- Oncology 101
- Cancer Research 58
- Immunology and Allergy 19
- Molecular Biology 129
- Pathology and Forensic Medicine 25
Countries citing papers authored by Jun Meng
This map shows the geographic impact of Jun Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Meng more than expected).
Fields of papers citing papers by Jun Meng
This network shows the impact of papers produced by Jun Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Meng. The network helps show where Jun Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 125 | |
| 2 | 2019 | 59 | |
| 3 | 2020 | 34 | |
| 4 | 2018 | 31 | |
| 5 | 2021 | 25 | |
| 6 | CDC20: a novel therapeutic target in cancer. | 2023 | 21 |
| 7 | 2012 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 2013 | 16 | |
| 10 | 2018 | 14 | |
| 11 | 2014 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 8 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2022 | 2 | |
| 20 | Serum proteomic spectra of esophageal carcinoma patients and a corresponding esophagial carcinoma diagnostic model. | 2009 | 1 |
About Jun Meng
Jun Meng is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 23 papers that have together received 422 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Asthma and respiratory diseases (2 papers), Heavy Metal Exposure and Toxicity (1 paper), Adaptive Control of Nonlinear Systems (1 paper), Maternal Mental Health During Pregnancy and Postpartum (1 paper), Microtubule and mitosis dynamics (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (101 citations), Cancer Research (58 citations), Immunology and Allergy (19 citations), Molecular Biology (129 citations) and Pathology and Forensic Medicine (25 citations). Jun Meng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guifang Li, Yanyan Yu, Lu Liu, Cong Tan, Yongping Liu, Weiqi Sheng, Yunpu Wang, Weiwei Weng, Lu Gan and Ming Huang. Their work appears in journals such as Experimental Cell Research, Genes & Diseases, Life Sciences, Frontiers in Medicine and Stress and Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.